Related Experiment Videos
Loop-acting diuretics do not bind to Tamm-Horsfall urinary glycoprotein.
M C Brunisholz1, K L Lynn, J S Hunt
1Department of Nephrology, Christchurch Hospital, New Zealand.
Clinical Science (London, England : 1979)
|September 1, 1987
Summary
Loop diuretics like frusemide bind strongly to albumin in vitro but not to Tamm-Horsfall glycoprotein. This study suggests binding to Tamm-Horsfall glycoprotein is not key to loop diuretic action.
Area of Science:
- Pharmacology
- Nephrology
- Biochemistry
Background:
- Loop-acting diuretics are crucial for managing fluid balance.
- Their interaction with urinary proteins like Tamm-Horsfall glycoprotein (THG) is not fully understood.
- Understanding these interactions may elucidate diuretic mechanisms.
Purpose of the Study:
- To investigate the in vitro and in vivo binding of radiolabelled loop diuretics to human serum albumin (HSA) and THG.
- To determine the role of THG binding in the diuretic action of these drugs.
Main Methods:
- In vitro equilibrium dialysis was used to assess binding between [14C]frusemide, [14C]ethacrynic acid, and [3H]bumetanide with HSA and THG.
- In vivo studies in rabbits examined the diuretic effect and THG binding of these diuretics after intravenous administration.
Main Results:
- All tested loop diuretics ([14C]frusemide, [14C]ethacrynic acid, [3H]bumetanide) exhibited strong in vitro binding to HSA but not to THG.
- In rabbits, frusemide and bumetanide induced diuresis, while ethacrynic acid did not.
- No in vivo binding to THG was observed for any of the diuretics during their diuretic action in rabbits.
Conclusions:
- The strong in vitro binding of loop diuretics to HSA is confirmed.
- Binding to Tamm-Horsfall glycoprotein does not appear to be a significant factor in the diuretic efficacy of loop-acting diuretics.
- Further research may focus on other mechanisms of loop diuretic action.